The few years after 2013 saw a drop in clinical research being done in India, on account of regulatory uncertainty, judicial and social activism, and media sensationalism. This made the clinical research fraternity disturbed and concerned. The Ministry of Health and Family Welfare then took steps to address the challenges posed by regulatory uncertainty. Regulations were amended, and guidance was given on existing ones. These were very significant moves to help the clinical research industry mend itself and move forward to a positive commitment.
The changes that have been brought about have brought immense success to the clinical research industry. But, these changes definitely need to be sustained for better outcomes. Indian regulators have adopted an inclusive approach, where multi-stakeholder feedback has been actively sought and acted upon. This must also be continued. The entire regulatory system must be balanced, and aligned with global trends. In fact, all the developments made must send out a strong signal to the global clinical research community that we are committed to a robust regulatory environment with focus on patient safety, protection, and transparency. When elements like informed consent, transparency, restricting the liability of sponsors, registrations, and applicability of stringent laws are all balanced together can help India go a long way to strike a balance between the interest of subjects and growth of clinical trials in India.
With all the changes made, India is ready to compete with international standards of health services. This is why many companies are re-investing in India for their research and development. At present, the Indian environment is again becoming advantageous for conducting clinical trials. However, it is essential that the goal should be conducting quality trials that bring the best outcomes, while assuring patient protection and data integrity of the trial. A genetically diverse patient pool, a vast population in need of medical treatment, a large disease burden, qualified medical professionals, data specialists, clinicians, and good regulatory practices as per global standards – all of this make India a favourable destination for clinical research in the future.
This clearly shows that opting for a career in clinical research will bring bright prospects. So, getting trained at the right institute will bring you a bright clinical research career. Avigna Clinical Research Institute is one of the top clinical research institutes in Bangalore that is dedicated to provide excellent clinical research education to numerous students from different fields. Big pharmaceutical companies, health organizations, and medical service providers require professional clinical researchers for their research and development. Avigna has the best placement record in the industry as it provides 100% placement and internship assistance guarantee after training, in top CROs, pharmaceuticals, and bio-tech companies. We are clearly the market leaders in innovation in terms of our self-designed, up-to-date industry integrated curriculum, and the technical and soft skills that we impart to our students, while making them apt for modern technology usage. So, when you see yourself having a career in clinical research, get enrolled with Avigna, and you could go places, not only in India, but also internationally!
